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Abstract
We correlated mineralogical and particle characteristics of Zn-containing particles with Zn
geoavailability, bioaccessibility, and bioavailability following gavage and intranasal (IN)
administration in rats. We compared samples of Zn/Pb mine waste and five pulverized pure-phase
Zn minerals (<38 μm). Particles were neutron-activated to produce radioactive 65Zn. We assessed
geoavailability using sequential extractions and bioaccessibility using in vitro extraction tests
simulating various pH and biological conditions. Zn in vivo bioavailability and in vitro
bioaccessibility decreased as follows: mine waste > hydrozincite > hemimorphite > zincite ≈
smithsonite ≫ sphalerite. We found significant correlations among geoavailability,
bioaccessibility and bioavailability. In particular, Zn bioavailability post-gavage and post-IN was
significantly correlated with bioaccessibility in simulated phagolysosomal fluid and gastric fluid.
These data indicate that solid phase speciation influences biological uptake of Zn and that in vitro
tests can be used to predict Zn bioavailability in exposure assessment and effective remediation
design.
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1. Introduction
Remediation of contaminated sites requires accurate assessments of risk, yet total
contaminant concentrations alone are often poor predictors of uptake and toxicity. Human
health risks from contaminants are determined by inherent chemical toxicity, extent of
exposure and contaminant bioavailability (fraction of a contaminant in exposure media that
can be absorbed by organisms). Thus, evaluating bioavailability can improve dose
estimation from exposure assessment (Kobayashi and Okamura, 2005; Milton and Johnson,
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1999; Ruby et al., 1996). Metals are common contaminants at mining and other
contaminated locations. Children are especially vulnerable to metal-contaminated soils and
indoor dust. Hand-to-mouth and inhalation exposures in playgrounds and home
environments are common.
In addition to bioavailability, metal mobility in the environment and biological uptake are
influenced by two other related parameters: geoavailability and bioaccessibility.
Geoavailability describes the release of metals from solid phases under environmentally
relevant conditions. It is the fraction of total metals that can be released to the biosphere
through mechanical, chemical and biological processes (Smith, 2007). Bioaccessibility
describes the ability of a metal to be solubilized in a biological fluid after ingestion, such as
gastric fluid (following oral ingestion) or phagolysosomal fluid (following macrophage
uptake after inhalation).
Multiple mechanisms control absorption of particle-bound metals. Oral bioavailability is
influenced by physiological factors such as fasted/fed state, associated motility, gastric
emptying, intestinal transit time, variability in gastrointestinal (GI) contents and nutritional
status (Amidon et al., 1995). For instance, iron (Fe) status regulates expression of divalent
metal transporter 1 (DMT1), which mediates absorption of Fe and many other divalent
metals such as manganese (Mn), zinc (Zn), cadmium (Cd), and lead (Pb) (Au et al., 2008).
In the respiratory tract, inhaled airborne particles may be deposited depending on their
aerodynamic size. The majority (92%) of larger particles (>8 μm) deposit in nasal passages
and upper airways, while inhaled smaller particles (≤2 μm) deposit in the deep lung (93–
97%) where they are phagocytized by macrophages (Brain and Valberg, 1979; Heyder and
Svarten, 2002).
Bioavailability also varies widely depending on properties of the metal, metal speciation
(distribution among various chemical forms), particle size, morphology, and solubility.
Metal sulfides and some other primary metal ores tend to have low bioavailability (Ruby,
2004). However, metal ores undergo temporal shifts in speciation that can affect
bioavailability. For example, weathering of sulfide minerals in the presence of oxygen can
result in speciation changes and the formation of secondary mineral phases that often have
greater bioavailability than the parent ore. Metals can also decrease in bioavailability as they
become more strongly incorporated into the soil matrix. Temporal variability in metal
bioavailability highlights the value of repeated sampling over time.
In vivo determination of metal bioavailability in animal models is time-consuming and
expensive. Moreover, the results must be extrapolated to humans. Thus, simpler in vitro
bioaccessibility tests to estimate bioavailability would be valuable. Several studies have
estimated oral bioavailability of metals in contaminated soils and mine wastes using in vitro
tests with a single extraction or series of extractions designed to mimic the GI system
(Bradham et al., 2011; Casteel et al., 2006; Juhasz et al., 2009a; Juhasz et al., 2009b;
Navarro et al., 2006; Ruby et al., 1996; Schroder et al., 2004). These studies concluded that
the characteristics of each metal (Navarro et al., 2006), pH of the extraction solution (Juhasz
et al., 2009a; Juhasz et al., 2009b; Ruby et al., 1996), mineralogical composition of samples
(Bradham et al., 2011; Navarro et al., 2006), matrix properties and presence of other organic
or inorganic components (Casteel et al., 2006) significantly influenced bioaccessibility.
Validation of in vitro tests as predictors of bioavailability requires evaluating both
bioavailability and bioaccessibility on the same materials. Correlations between
bioaccessibility and bioavailability have been established for Cd (Juhasz et al., 2010;
Schilderman et al., 1997), Pb (Casteel et al., 2006; Kelley et al., 2002; OSWER, 2004; Ruby
et al., 1996) and As (Bradham et al., 2011; Juhasz et al., 2009b). Studies of Pb- and As-
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contaminated soils showed that in vitro extraction results successfully predicted Pb
bioavailability in rats, but over-predicted As bioavailability in rabbits and primates (Ruby et
al., 1996). Bioaccessibility of Cd in contaminated soils extracted in simulated gastric or
intestinal fluids was significantly correlated with relative bioavailable Cd in swine (Schroder
et al., 2004).
Less is known about relationships between bioaccessibility and bioavailability for
micronutrient metals such as Zn, Cu and Mn. While the consequences of Zn deficiency are
well known (Otten et al., 2006), Zn is also among the top 100 hazardous substances on the
U.S. Agency for Toxic Substances and Disease Registry’s Substance Priority List (ATSDR,
2012). Toxicity from excessive intake of Zn is increasingly recognized, including inhalation
of zinc oxide fumes in workplaces or polluted environments (El Safty et al., 2008).
Consequences include Cu deficiency, immune dysfunction, anemia and other hematological
abnormalities (Fosmire, 1990). To our knowledge, there have been no systematic
comparisons of Zn bioaccessibility and bioavailability across a range of chemical forms and
routes of exposure.
The goals of this study were to determine whether Zn bioavailability and bioaccessibility are
influenced by mineralogy and particle characteristics and the extent to which these in vitro
bioaccessibility tests and geochemically-based sequential extractions may predict in vivo
bioavailability. We determined Zn geoavailability, in vitro bioaccessibility, and in vivo
bioavailability following gavage and intranasal administration of five Zn minerals and a Zn-
rich mine waste sample. These exposure pathways were selected since larger airborne
particles from piles of mine wastes are more likely deposited in the nose than in the lungs
and are likely to be ingested via hand-to-mouth transfer, especially by children playing in
contaminated sites. We compared common pure-phase Zn minerals with Zn-rich mine waste
containing a complex mixtures of different phases. Studying pure phase Zn minerals allows
us to directly evaluate the effect of mineralogy on bioavailability and bioaccessibility, and
other factors that may affect metal mobility such as organic matter, iron oxides, and cation
exchange capacity.
2. Materials and methods
2.1 Particle characterization
We obtained samples of smithsonite [ZnCO3], hydrozincite [Zn5(CO3)2(OH)6],
hemimorphite [Zn4Si2O7(OH)2·H2O], sphalerite [(Zn,Fe)S] and zincite [(Zn,Mn)O] (Table
1) from the Harvard University Mineralogical Museum (Cambridge, MA). Samples were
ground with a mortar and pestle and then sieved through a 38-μm pore-sized brass sieve
with stainless steel wire. In addition, a sample of weathered mine waste collected from a pile
at the Tar Creek Superfund Site (Oklahoma, U.S.A.) was air-dried at room temperature and
sieved to <38 μm without grinding. This site was a former Pb and Zn mine where the major
ores produced were sphalerite and galena (PbS) (McKnight and Fischer, 1970). The high Zn
concentrations (up to 22% Zn by mass in <1 μm particles) in mine waste (Schaider et al.,
2007) raise concerns about elevated Zn exposures for residents. Previous analyses of the <38
μm mine waste samples using X-ray diffraction showed that 20–35% of Zn was present as
hemimorphite and sphalerite and the majority in poorly crystalline secondary mineral forms
(Schaider et al., 2007). These particles are small enough to be transported by wind (Duggan
et al., 1985) and deposited in the nose and oral pharynx (Brain and Valberg, 1979).
All samples were divided into three aliquots. One was analyzed for specific surface area
(SSA) by the Brunauer-Emmett-Teller (BET) method of N2 adsorption at the National
Institute for Occupational Safety and Health (Morgantown, WV) (Brunauer et al., 1938).
The second set of aliquots was analyzed for size, morphology and elemental composition.
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Aqueous suspensions of particles were analyzed for size distribution in a Beckman-Coulter
LS 13 320 Laser Diffraction Particle Size Analyzer (LDPSA) (Beckman Coulter, Inc., Brea,
CA). Similar suspensions of particles were spread onto carbon adhesive tabs on aluminum
scanning electron microscopy (SEM) specimen mount stubs (Electron Microscopy Sciences,
PA). After drying under vacuum, morphology and elemental composition were assessed
using a Leo 1450 VP scanning electron microscope with energy-dispersive X-ray
spectroscopy (SEM-EDX) at 15 kV (Carl Zeiss SMT, Inc., Thornwood, NY). Dry samples
of minerals were also analyzed with X-ray diffraction for phase verification.
The third set of aliquots was neutron-activated at the MIT Nuclear Reactor Laboratory
(Cambridge, MA) with a thermal neutron flux of 5 × 1013 n/cm2s for 120 hours (mine
waste) or 6 hours (pure-phase Zn minerals). Longer neutron activation of mine waste was
necessary because the Zn concentration was lower. Neutron irradiation generated 65Zn,
which decays with a half-life of 244.3 days and emits gamma energies of 345, 770 and 1115
keV. These radioactive particles were used in in vitro extractions and geochemically-based
extractions and in pharmacokinetic studies in rats. Specific activities for 65Zn in each
particle are listed in Table 1 and reflect their respective Zn concentration. Major and trace
elemental composition of the mine waste was determined with instrumental neutron
activation analysis.
2.2 In vitro extraction tests
We used a range of pH and chemical conditions to measure in vitro bioaccessibility.
Simulated gastric fluid extraction was performed in a pH 1.5 fluid (1 hour, 37°C) (OSWER,
2007). A pH 4.5 weak salt solution (5 days, 37°C) was used to simulate some biological
environments such as phagolysosomal fluid in phagocytic cells (Stefaniak et al., 2005). A
pH 7.4 solution (1 hour, 37°C) was used to simulate the conditions in the nasal epithelium
and oropharynx. All extractions were performed with constant mixing using an Adams
nutator Model 1105 (Clay Adams, Parsippany, NJ) at 12 rpm. Extraction solutions were
filtered through a 0.2 μm syringe tip filter to remove particle-bound 65Zn. Since some
particles may be smaller than 0.2 μm, the filtrate was then centrifuged at 317,000 x g and the
supernatant was carefully removed. This extra step reduced the probability of
measuring 65Zn in very small particles that may pass through the filter. For each extraction,
bioaccessibility was calculated as the percent of total 65Zn that was dissolved and present in
the filtered and ultracentrifuged solution.
Simulated gastric fluid extractions followed a protocol developed by the U.S. Environmental
Protection Agency (USEPA) for Pb and validated with in vivo results (OSWER, 2007). The
solid:liquid ratio was modified to 1:1000. While the method recommends a solid:liquid ratio
of 1:100, it also notes the potential for precipitation of dissolved metal when extractions are
performed on solid phases with concentrations above 50,000 ppm (OSWER, 2004, 2007).
The pure phase Zn minerals used in this study had 52–73% Zn by mass. To maintain the
same limit on Zn concentration in solution implies that a solid:liquid ratio of 1:1000 is
appropriate. Although Zn is more soluble than Pb (used for validation), a similar limit on
metal concentration in solution was selected to minimize potential precipitation of other
secondary mineral phases.
2.3 Geochemically-based sequential extractions
Geochemically-based sequential extractions were performed on the six particle samples.
This protocol uses a series of increasingly stringent solutions selected to extract metals in 5
operationally defined phases: (I) ion-exchangeable (1 M MgCl2, pH 7, 1 h); (II) carbonate (1
M Na acetate, pH 5, 5 h); (III) reactive sulfide (1 M HCl, 12 h); (IV) crystalline sulfide
(concentrated HNO3, 2 h); and (V) residual (remainder after previous extraction steps). The
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protocol was adapted from published methods (Bostick et al., 2001; Huerta-Diaz and Morse,
1992; Keon et al., 2001; Tessier et al., 1979). The solid:liquid ratio was similarly modified
to 1:1000.The first two steps encompass parameters that may realistically be found under
environmental conditions. Thus, the sum of metals extracted in these two steps can be
considered geoavailable.
2.4 In vivo bioavailability studies
The protocols were approved by the Harvard Medical Area Animal Care and Use
Committee. Weanling Sprague-Dawley male rats were obtained from Taconic Farms
(Germantown, NY) and housed at the Harvard Center for Comparative Medicine. They had
access to commercial chow (PicoLab Rodent Diet 5053, Framingham, MA) and water ad
libitum. All animals were acclimatized to our facilities for a week before starting the
experiments. Neutron-activated mine waste and Zn mineral particles were suspended in
phosphate-buffered saline solution (PBS) at 25 mg/ml for intranasal (IN) (0.2 ml/kg body
weight) or at 3.33 mg/ml for gavage administration (1.5 ml/kg). Particles in suspension were
dispersed using a bath sonicator for five minutes before dosing. Aliquots of each suspension
were measured in a Packard gamma counter (Cobra Quantum, Packard Instrument, Downers
Grove, IL), and specific activities were calculated (Table 1). The particle dose was 5 mg/kg
for both routes of administration. Based on particle Zn concentrations, the estimated Zn dose
ranged from 0.5 to 3.65 mg/kg body weight. Soluble 65ZnCl2 (specific activity = 2.39 mCi/
mg) was obtained from Perkin Elmer (Billerica, MA) and administered at the same volume
doses and at a dose of 0.006 mg Zn/kg and 16.1 μCi 65Zn/kg body weight.
Before IN instillation or gavage, rats were anesthetized with isoflurane (Halocarbons Lab,
Inc., North Augusta, SC). The particle suspension or soluble 65ZnCl2 was instilled into the
nasal cavity. Gavage administration was performed in similarly anesthetized rats, placed on
a slanted board where they were supported by an elastic band under the upper incisors. Each
dose was instilled into the stomach using a gavage needle inserted transorally through the
esophagus to the stomach. All rats (six per group) were dosed twice weekly for three weeks
to simulate continuous exposure likely to occur in exposed populations. Rats were sacrificed
and tissue 65Zn levels were analyzed four days after the last dosing. The whole brain, spleen,
kidneys, heart, , liver, lungs, GI tract, testes and multiple samples of blood, bone marrow,
skeletal muscle, and skin were collected, weighed, and analyzed in a gamma counter. We
did not collect and analyze urine and feces and so the amount of 65Zn that was first absorbed
and then excreted cannot be estimated. Absolute bioavailability (ABA) was calculated as the
percentage of the total 65Zn dose retained in each organ. The sum of all analyzed organs and
tissues was considered as the total ABA. Relative bioavailability (RBA) was calculated as
ABA of each particle sample relative to 65ZnCl2.
2.5 Statistical analyses
Differences in the 65Zn tissue distribution among the particles were analyzed using
multivariate analysis of variance (MANOVA) with Bonferroni (Dunn) post hoc tests using
SAS Statistical Analysis software (SAS Institute, Cary, NC). In vitro extraction assays,
sequential extractions and particle characteristics were tested as predictors of ABA with
multivariate linear regression analyses using Stata/SE statistical software (StataCorp LP,
College Station, TX). Bioaccessibility, sequential extraction and bioavailability data were
logit transformed to meet assumptions of normality.
3. Results and discussion
We compared in vitro extractions and geochemically-based extractions with in vivo
bioavailability of Zn in five pure-phase Zn minerals and a Zn-rich mine waste in rats. We
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also examined the influence of particle characteristics on bioavailability. By measuring Zn
dissolution from radioactive neutron-activated particles, we utilized a highly sensitive
method that measured only 65Zn released from the particles and excluded background Zn
from dietary sources. The sensitivity of 65Zn detection also avoided the use of high Zn doses
that may alter Zn homeostasis or saturate Zn transport mechanisms.
3.1 Particle morphology and elemental composition
Particles were examined by SEM (Figure 1), which revealed differences in size, shape and
morphology. The micrographs showed a high degree of heterogeneity in shapes and particle
sizes within and among samples. Elemental mapping using SEM-EDX in randomly selected
micrographs showed that Zn was uniformly distributed in these minerals, regardless of size
and shape. By comparison, mine waste particles had more heterogeneous elemental
distributions (data not shown). Approximately 35% of randomly selected mine waste
particles contained no detectable Zn. Elements associated with host rock minerals (chert,
dolomite) or other metal sulfides (FeS2, PbS) were also detected, including calcium,
magnesium, silicon, arsenic, lead, iron, aluminum, and sulfur. Other metals were also
detected in the Zn mineral particles. Zincite contained manganese, which typically co-occurs
with Zn in this mineral. Smithsonite contained some silicon, calcium and cadmium. XRD
analyses showed that hydrozincite hemimorphite, sphalerite, and zincite samples were pure
while smithsonite contained 13.1% quartz. Previous XRD analyses of the <38 μm mine
waste samples showed that 20–35% of Zn was present as hemimorphite and sphalerite and
the majority in poorly crystalline secondary mineral forms (Schaider et al., 2007).
3.2 Surface area and size distribution
Higher surface area of particles increases their dissolution rates (Kreyling et al., 1990) and
thus metal bioavailability. Our BET analyses showed that specific surface areas (SSA)
varied significantly (Table 1), with hydrozincite having 10 to 100 times greater SSA than the
other samples. Based on LDPSA analyses of particle size distributions (Table 1), mine waste
had the smallest geometric mean diameter while hemimorphite had the largest. Although
hydrozincite had the largest SSA according to BET analyses, its mean and mode particle
diameters were among the largest, suggesting that particle diameter, as measured by
LDPSA, does not necessarily reflect available surface area. As seen in Figure 1F, variable
particle shapes may account for these discrepancies.
3.3 In vitro bioaccessibility tests
Zn bioaccessibility varied widely depending on the mineral form and extraction conditions
(Table 2). Low Zn bioaccessibility was observed at pH 7.4; ≤0.1% of 65Zn was dissolved
from smithsonite, hydrozincite, zincite, and sphalerite and <1% of 65Zn was dissolved from
hemimorphite and mine waste. At pH 4.5, mine waste showed the highest bioaccessibility,
with 92% 65Zn dissolved into the extraction fluid. Smithsonite, hemimorphite, zincite and
hydrozincite showed moderate bioaccessibility (35–57%) and sphalerite showed minimal
bioaccessibility (1.1%). Zn bioaccessibility was consistently higher at pH 1.5 than at pH 4.5
or 7.4. Bioaccessibility at pH 1.5 was 98% for mine waste, and 96–97% for hemimorphite,
zincite, and hydrozincite. Smithsonite showed slightly lower bioaccessibility (72%), and
sphalerite again showed minimal bioaccessibility (1.7%).
Enhanced Zn bioaccessibility under more acidic conditions is consistent with previous
studies showing increased Zn mobility in soils at lower pH (Sauvé et al., 2000) and
increased bioaccessibility of As, Cd and Pb. Juhasz et al. (2009b) compared As
bioaccessibility in contaminated soils using four in vitro gastric fluid extraction solutions
(pH 1.5–2.5) and four in vitro intestinal extractions (pH 5.5–7.5). Similarly, Cd
bioaccessibility was higher in gastric fluid extractions than in intestinal fluid extractions, and
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among gastric fluid extractions, the pH 1.5 solution (same composition as in our study)
generally showed the highest bioaccessibility 1.5 (Juhasz et al., 2010). Arsenic
bioaccessibility was generally higher in gastric extractions than in intestinal extractions,
although the differences were less pronounced (Juhasz et al., 2009a).
3.4 Geochemically-based sequential extractions
Mine waste, hemimorphite, zincite and hydrozincite contained Zn in relatively labile phases
(Table 3). In these samples, 81–89% of 65Zn was present in extraction stage I and II,
representing geoavailable Zn. The majority of remaining Zn (10–16%) was present in stage
V (residual fraction), with ≤2% present in stages III and IV. Consistent with in vitro
extraction results, sphalerite was the least labile mineral, with >90% of 65Zn extracted in
stages IV and V. Surprisingly, only 28% of 65Zn in smithsonite was dissolved in stage II,
with 57% of 65Zn in the stage III fraction. This may be due to presence of recalcitrant Si-
and Al-containing mineral impurities as well as kinetic constraints that may have led to low
dissolution of the carbonate mineral during the extraction period. In addition, for each type
of mineral, there may be a range of bioaccessibility depending on the properties of each
specific mineral sample. Results from geochemically-based sequential extractions should be
viewed as a guide since there are inherent limitations to sequential extractions, such as lack
of specificity and the potential sorption or re-precipitation of solubilized metals back onto
the solid sample surface (Kheboian and Bauer, 1987; Ostergren et al., 1999).
3.5 In vivo bioavailability of Zn after intranasal and gavage administration in rats
Absolute bioavailability results (Tables 4 and 5) showed that the overall organ distributions
for both IN and gavage administration were statistically different among particles and
compared to 65ZnCl2 (MANOVA, P<0.05). We considered the total percentage of 65Zn dose
in blood and all tissues examined as total ABA, an indicator of its retention in the body. In
general, total ABA after IN administration decreased in the following order: mine waste
> 65ZnCl2 > hydrozincite > hemimorphite > zincite > smithsonite > sphalerite (Table 4).
Interestingly, Zn ABA was higher for mine waste than dissolved 65ZnCl2. We hypothesize
that Zn ions from ZnCl2 may quickly form conjugates with proteins in nasal or
gastrointestinal mucosa that attenuate their absorption, whereas interactions with Zn from
particles may be different due to slow dissolution. The highest amounts of 65Zn were found
in the skeletal muscle and liver, mainly due to their large weights. The 5 tissues and organs
with highest concentrations of 65Zn were hair, nails, teeth, bone marrow, and liver (data not
shown). The low levels of 65Zn in the lungs confirmed that very few IN administered
particles were aspirated into the lungs. Therefore, 65Zn in peripheral tissues primarily
reflects absorption through the nasal or intestinal epithelium.
A similar distribution of 65Zn among tissues was observed after gavage administration
(Table 5). Significant differences among the particles in Zn total ABA were observed in the
same decreasing order measured after IN administration. This suggests that tissue uptake
of 65Zn after IN dosing likely resulted from swallowed particles. Overall, ABA for 65Zn was
1.2 to 1.6 times higher following gavage compared to IN administration, suggesting greater
Zn bioavailability from ingested particles compared to particles deposited in the nasal
passage. These relative differences may be due to loss of a portion of the particles deposited
in the nasal cavity before being swallowed. ABA post IN and gavage ranged from 0.6 to
13.7% depending on particle type and route of exposure. Estimates of ABA may be slightly
underestimated due to the exclusion of urine (Johnson et al., 1988) and body clearance of Zn
over the study period. Other factors such as phytic acids in the chow (Davies and
Nightingale, 1975), iron and zinc status (Johnson et al., 1988; Miller et al., 1971), dietary
proteins (Mahalko et al., 1983), and ingestion of other metals also influence absorption and
excretion of Zn (Gooneratne et al., 2011). However, in our experiment, relative differences
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among particles are most likely due to the mineralogy and morphology of the particles
themselves, since these other factors did not vary in our experiment.
Few studies have compared bioaccessibility and bioavailability of Zn in animals. Zn
bioavailability from different grades of ZnO, and Zn metals relative to ZnSO4, were
significantly different confirming that chemical forms of Zn influence bioavailability
(Edwards and Baker, 1999). Another study compared Zn and Cu bioaccessibility with
bioavailability in lugworms (Arenicola marina) from contaminated marine sediments and
found that Zn bioaccessibility in fluids containing serum albumin (a surrogate for the gut
fluids of sediment feeders) did not correlate with bioaccumulation (Turner et al., 2008). Low
Zn bioavailability from inhaled zinc-cadmium sulfide was reported in rats (Bergmann et al.,
2000). Although previous studies have shown that Zn speciation influences bioaccessibility
and bioavailability, our study also compares these parameters across a broader range of
chemical forms as well as routes of exposure.
3.6 Correlation of mineralogy and particle characteristics with bioavailability and
bioaccessibility
Our results show that mineralogy influences bioavailability and bioaccessibility of Zn. Mine
waste particles had the highest bioavailability and bioaccessibility at pH 1.5 and 4.5,
consistent with our previous findings that the surface of these particles contained Zn in
secondary minerals that are poorly crystalline and relatively bioaccessible (Schaider et al.,
2007). Mine waste from the Tar Creek site has undergone weathering for at least 35 years.
Simulated aging of contaminated soil using EDTA leaching has been shown to increase Pb
and decrease Cd mobility and bioaccessibility, as determined by in vitro extractions,
whereas Zn bioaccessibility was not affected (Udovic and Lestan, 2009). Zn bioavailability
and bioaccessibility in sulfide form (sphalerite) were lowest, consistent with previous
studies (Bergmann et al., 2000; Klimisch, 1993). Surprisingly, zinc carbonate (smithsonite)
yielded lower bioavailability than hemimorphite. As noted in Section 3.4, a range of factors
may have limited the dissolution of smithsonite.
Other studies have shown that particle surface area influences bioavailability. We found that
SSA alone was not correlated with Zn ABA, although to some extent, particles with higher
SSA tended to have greater bioavailability. The highest SSA was measured for hydrozincite
(93.4 m2/g), which may have contributed to the relatively high tissue concentrations of Zn
after both IN and gavage administration of hydrozincite. This is followed by hemimorphite
(3.9 m2/g) and smithsonite (2.7 m2/g), particles with similar SSA and corresponding ABA.
Lower tissue 65Zn from zincite and sphalerite corresponded with their lower SSA. However,
mine waste had higher Zn bioavailability than hydrozincite despite having 10 times lower
SSA. Smithsonite and zincite showed similar Zn ABA, although smithsonite had 3 times
higher SSA. Although influenced by SSA, our results demonstrated that the mineralogical
form is a major determinant of Zn bioavailability.
3.7 Regression analyses of zinc in vitro bioaccessibility, in vivo bioavailability, and
geoavailability
While in vitro tests have been developed for assessing bioaccessibility in a risk assessment
context, geochemists have used sequential extractions as one method to assess metal lability
and to characterize the speciation of metals in solid phases (Tessier et al., 1979). Depending
on the extraction solutions used, sequential extractions may provide a measure of
geoavailability. Thus, we conducted regression analyses to examine whether in vitro
measures of zinc bioaccessibility were correlated with geoavailability as measured by
sequential extractions and with in vivo bioavailability, and whether geoavailability was
correlated with in vivo bioavailability (Table 6).
Molina et al. Page 8
Environ Pollut. Author manuscript; available in PMC 2014 November 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
A significant relationship was observed between bioavailability and in vitro bioaccessibility.
In vivo bioavailability post-IN installation was significantly correlated with bioaccessibility
at pH 4.5 (R2=0.86, p=0.005) and at pH 1.5 (R2=0.79, p=0.01). In vivo bioavailability post-
gavage was significantly correlated with bioaccessibility at pH 4.5 (R2=0.83, p=0.008) and
at pH 1.5 (R2=0.72, p=0.02). Finally, correlation coefficients between bioavailability post-
IN and post-gavage with geoavailability were 0.67 (p=0.03) and 0.60 (p=0.04), respectively.
Both in vitro bioaccessibility tests appeared to overpredict absolute bioavailability estimated
as the total retained dose. One reason for this apparent overprediction is that part of the
bioavailable Zn absorbed by the animals was excreted over the course of three-week dosing
experiment. When comparing in vitro bioaccessibility with IN absolute bioavailability, the
slopes of the relationship were y=0.062x – 0.0014 (pH 1.5) and y = 0.114 – 0.0031 (pH 4.5).
For gavage ABA, the slopes were y=0.083x – 0.0003 (pH 1.5) and y=0.151x – 0.002 (pH
4.5). Figure 2 shows correlation of bioaccessibility at pH 4.5 on in vivo RBA of 65Zn
(relative to ZnCl2) post-gavage (Fig 2A) or post-IN instillation (Fig 2B). The strengths of
the correlations are shown by the high R2. In both instances, variability in in vitro
bioaccessibility accounted for 88% of the variability observed in in vivo bioavailability.
Zinc geoavailability (sequential extraction fractions I + II) was also correlated with
bioaccessibility when particle size (mean diameter in LDPSA analyses) was included in the
regression models (pH 4.5, R2=0.98, p=0.002 and pH 1.5, R2=0.99, p<0.0001). The particle
size term in the regression models had negative coefficients (Table 6), indicating that larger
particles had lower bioaccessibility.
Thus, our data showed that in vitro bioaccessibility tests with simulated gastric fluid
extraction or phagolysosomal environment correlate strongly with in vivo bioavailability of
Zn from particles of different mineralogy either after being ingested or deposited into the
nasal passages.
4. Conclusions
Our data show that in vivo bioavailability of Zn from pure-phase minerals and a complex
mixture of Zn phases (mine waste) depends on the chemical form of Zn, particle size, and
route of exposure. The trends observed in in vitro extractions and geochemically-based
sequential extractions were consistent with the in vivo results. The significance of these
correlations confirms that solid phase speciation and geochemical alteration of speciation
during weathering can have significant impacts on the biological uptake of zinc. Our study
shows that in vitro tests can predict relative bioavailability of micronutrient metals such as
Zn and can be useful in exposure assessment and for determining the efficacy of remediation
strategies.
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Highlights
• Zinc particle mineralogy influences bioaccessibility and bioavailability.
• Zn bioavailability via gavage was 1.2–1.6 times higher than via intranasal route.
• Zn particle geoavailability correlates with bioaccessibility.
• In vitro bioaccessibility tests can predict in vivo Zn bioavailability
• Metal speciation and geochemical alterations can impact Zn bioavailability.
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Figure 1.
Scanning electron micrographs of particles. Representative images from mine waste (A),
hemimorphite (B), zincite (C), smithsonite (D), sphalerite (E) and hydrozincite (F) obtained
using the backscatter mode. Micron bar = 10 μm. Brighter areas have higher average atomic
number and indicate areas enriched in zinc and other metals.
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Figure 2.
Regression analysis of bioaccessibility at pH 4.5 on in vivo RBA of 65Zn (relative to ZnCl2)
after IN (2A) or gavage (2B) administration. The in vitro extraction results significantly
correlated with both post-intranasal (r2=0.88) and post-gavage (r2=0.88) Zn relative in vivo
bioavailability. n=6 rats per group.
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Table 2
Results of in vitro extraction tests. Results are presented as percentage of total 65Zn measured in dissolved
extraction solution after each specified time of incubation.
pH 7.4a pH 4.5b pH 1.5c
1 h 5 d 1 h
Mine waste 0.22 91.7 98.2 ± 5.1
Hydrozincite 0.09 56.8 97.4 ± 3.7
Hemimorphite 0.48 39.1 95.8 ± 1.4
Zincite 0.06 35.0 96.5 ± 1.8
Smithsonite 0.09 36.4 72.1 ± 9.4
Sphalerite 0.03 1.07 1.7 ± 0.4
apH 7.4: 137 mM NaCl, 2.7 mM KCl, 8.1 mM Na2HPO4 · 2 H2O, 1.76 mM KH2PO4
bpH 4.5: 20 mM KHC8H4O4, 110 mM NaCl, 6.0 mM glycine, 1.0 mM Na2HPO4, 0.5 mM Na2SO4, 0.20 mM CaCl2, 50 ppm benzalkonium
chloride
cpH 1.5: 0.4 M glycine. Results expressed as mean ± SE (n=2).
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